4.7 Article

Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)2D3: Is It Really the Vitamin D3 Upregulated Protein?

期刊

出版社

MDPI
DOI: 10.3390/ijms19030796

关键词

vitamin D; TXNIP; VDUP1; cancer

资金

  1. German Academic Exchange Service (DAAD)
  2. Deutsche Forschungsgemeinschaft
  3. Baden-Wurttemberg Ministry of Science, Research and the Arts
  4. Ruprecht-Karls-Universitat Heidelberg

向作者/读者索取更多资源

Thioredoxin-interacting protein (TXNIP) was originally identified in HL-60 cells as the vitamin D-3 upregulated protein 1, and is now known to be involved in diverse cellular processes, such as maintenance of glucose homeostasis, redox balance, and apoptosis. Besides the initial characterization, little is known about if and how 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] induces TXNIP expression. We therefore screened multiple cancerous cell lines of different tissue origins, and observed induction, repression, or no change in TXNIP expression in response to 1,25(OH)(2)D-3. In-depth analyses on HL-60 cells revealed a rapid and transient increase in TXNIP mRNA levels by 1,25(OH)(2)D-3 (3-24 h), followed by a clear reduction at later time points. Furthermore, a strong induction in protein levels was observed only after 96 h of 1,25(OH)(2)D-3 treatment. Induction of TXNIP expression by 1,25(OH)(2)D-3 was found to be dependent on the availability of glucose in the culture medium, as well as the presence of a functional glucose transport system, indicating an inter-dependence of 1,25(OH)(2)D-3 actions and glucose-sensing mechanisms. Moreover, the inhibition of de novo protein synthesis by cycloheximide reduced TXNIP half-life in 24 h, but not in 96 h-1,25(OH)(2)D-3-treated HL-60 cells, demonstrating a possible influence of 1,25(OH)(2)D-3 on TXNIP stability in long-term treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据